Several analysts working on Wall Street have expected that the stocks of DKNG would be announcing an EPS of around $0.57 for the current quarter. Around seven of the investment analysts have already given out estimates into the earnings of the company. The ball has been rolled at a sum of $0.41, with the highest going in at $0.41. DKNG will be reporting its next quarterly results on the 26th of February.
Stock Commentary On DKNG
There have been quite a few research equities that have already commented on the stocks of DKNG. JPMorgan Chase & Co have already covered the company in a 7th December research note where they gave it a rating of neutral. The price target set on the firm was $48.
Truist has increased the price target on the company from a sum of $48 to $60, which was later published in a research note on the 14th of January. Oppenheimer reaffirmed their rating of buy along with a target price of $65 on the shares of the company. Morgan Stanley increased the rating of the company from equal weight to overweight. The price target was similarly increased from $39 to $60, in a 20th January research note. In the end, UBS Group also ended up putting up a rating of neutral with a $52 price target.
Two of the investment analysts have already given the stocks of this company a rating of sell. Six investment analysts have provided DKNG with a rating of hold. On the other hand, twenty analysts have issued the company a rating of buy. Currently, the company has a rating of buy, with a $58.68 price target.
DKNG traded on Thursday at $0.67. The year low of the company has been set at $10.60, while the year high of the company has been fixed at $64.78. The moving average price of the company over a period of 50-days is $54.81, while the same over 200-days is $47.53.
